Insider transactions

EDGAR

Xenetic Biosciences, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–5 of 5

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-04-21 Filed 2026-04-23PARSLOW JAMES F Officer: Interim CEO and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)100,0000—100,000Direct (D) Yes
F1
  • F1 This represents a restricted stock grant (RSG). The shares represented by the RSG will vest and become exercisable as follows: 7,000 shares shall vest on the date of grant and one-third of the remaining (93,000) shares shall vest on each of the first, second and third anniversaries of April 21, 2026.
Open filing 0001683168-26-003163 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-05Kornberg Roger D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (2,500) — exercise price 2.17
Acquired (A)2,5000—2,500Direct (D) No
F1
  • F1 The Options vest 100% on the twelve-month anniversary of the grant date.
Open filing 0001683168-26-000102 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-05Dastoor Firdaus J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (2,500) — exercise price 2.17
Acquired (A)2,5000—2,500Direct (D) No
F1
  • F1 The Options vest 100% on the twelve-month anniversary of the grant date.
Open filing 0001683168-26-000103 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-05Borisenko Grigory G. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (2,500) — exercise price 2.17
Acquired (A)2,5000—2,500Direct (D) No
F1
  • F1 The Options vest 100% on the twelve-month anniversary of the grant date.
Open filing 0001683168-26-000101 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-05VINOGRADOV ALEXEY ANDREEVICH Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (2,500) — exercise price 2.17
Acquired (A)2,5000—2,500Direct (D) No
F1
  • F1 The Options vest 100% on the twelve-month anniversary of the grant date.
Open filing 0001683168-26-000104 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–14 of 14

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager55,040 SH127,693 dollarsLower by 62,400 Prior quarter: 117,440Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
HRT FINANCIAL LP 29,641 SH68 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager17,423 SH40,439 dollarsUnchanged Prior quarter: 17,423Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager15,346 SH35,603 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 12,681 SH29,420 dollarsUnchanged Prior quarter: 12,681Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 11,547 SH26,789 dollarsNot in the prior quarter’s filings read Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Allworth Financial LP 6,406 SH14,862 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-044466 Filed 2026-11-17 Dispute this row
JTC Employer Solutions Trustee Ltd 2,700 SH6 dollarsUnchanged Prior quarter: 2,700Open filing 0001875645-26-000006 Filed 2026-11-09 Dispute this row
JONES FINANCIAL COMPANIES LLLP Partly reported under another manager1,466 SH3,504 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager1,013 SH2,350 dollarsNot in the prior quarter’s filings read Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
SBI Securities Co., Ltd. 1,003 SH2,327 dollarsHigher by 3 Prior quarter: 1,000Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
MORGAN STANLEY Partly reported under another manager150 SH348 dollarsUnchanged Prior quarter: 150Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Darwin Wealth Management, LLC 2 SH4 dollarsUnchanged Prior quarter: 2Open filing 0001663224-26-000005 Filed 2026-11-09 Dispute this row
Parallel Advisors, LLC 1 SH2 dollarsNot in the prior quarter’s filings read Open filing 0001690010-26-000007 Filed 2026-11-03 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Tower Research Capital LLC (TRC) 696 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
MJL Manager LLC Common Stock, $0.001 par value per share0.00.0009/16/2026 Filed 2026-09-18SCHEDULE 13GOpen filing 0002103370-26-000003 Dispute this row
Michael Liu Common Stock, $0.001 par value per share0.00.0009/16/2026 Filed 2026-09-18SCHEDULE 13GOpen filing 0002103370-26-000003 Dispute this row
Renaissance Technologies LLC Common Stock, $0.001 par value per share2.3555,04007/01/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 2Open filing 0001037389-26-000072 Dispute this row
Renaissance Technologies Holdings Corporation Common Stock, $0.001 par value per share2.3555,04007/01/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 2Open filing 0001037389-26-000072 Dispute this row
MJL Manager LLC Common Stock, $0.001 par value per share4.193,565.0005/22/2026 Filed 2026-05-29SCHEDULE 13GOpen filing 0002103370-26-000001 Dispute this row
Michael Liu Common Stock, $0.001 par value per share5.5126,741.0005/22/2026 Filed 2026-05-29SCHEDULE 13GOpen filing 0002103370-26-000001 Dispute this row
Renaissance Technologies LLC Common Stock, $0.001 par value per share6.00137,44003/31/2026 Filed 2026-05-14SCHEDULE 13G/AAmendment 1Open filing 0001037389-26-000042 Dispute this row
Renaissance Technologies Holdings Corporation Common Stock, $0.001 par value per share6.00137,44003/31/2026 Filed 2026-05-14SCHEDULE 13G/AAmendment 1Open filing 0001037389-26-000042 Dispute this row
Renaissance Technologies LLC Common Stock, $0.001 par value per share7.79178,50910/27/2025 Filed 2026-02-12SCHEDULE 13GOpen filing 0001037389-26-000022 Dispute this row
Renaissance Technologies Holdings Corporation Common Stock, $0.001 par value per share7.79178,50910/27/2025 Filed 2026-02-12SCHEDULE 13GOpen filing 0001037389-26-000022 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,124

Filings made before the SEC required XML are listed, not extracted.

Back to Xenetic Biosciences, Inc.